glp 1 agonist lilly Lilly's Easy-to Use Once-Weekly GLP-1 Trulicity Approved in Europe As GLP-1 Use Expands, Long-Term

Key players in the biosimilars market include Sandoz Group AG (Switzerland), Pfizer Inc

Both contain the same active ingredient, semaglutide, and are made by Novo Nordisk

Some medications to watch out for include: Medications used to treat type 1 or type 2 diabetes, including insulin or sulfonylureas (such as Amaryl or Glucotrol XL)

The company has reformulated the drug to improve tolerability, reflecting the industry's broader effort to develop more patient-friendly alternatives to injectable therapies

At the cellular level, GLP-1 receptor activation appears to reduce the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)